Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FBLG
#3765
FibroBiologics, Inc. Common Stock
0.3
3
+17.86%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+17.86%
Monthly Change
-8.33%
6 month change
-45.90%
Year Change
-72.73%
Previous Close
0.2
8
Open
0.3
3
Bid
Ask
Low
0.3
3
High
0.3
3
Volume
3
Markets
US Stock Market
Healthcare
FBLG
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
33.92 M
35.09 M
37.74 M
40.86 M
48.26 M
66.52 M
193.38 M
Valuation ratios
Enterprise value
99.27 M
70.95 M
25.77 M
17.26 M
23.21 M
10.31 M
76.55 M
Price to earnings ratio
-5.24
-5.88
-4.29
-1.73
-1.14
-0.54
-7.69
Price to sales ratio
—
71.47
—
—
4.73
2.95
—
Price to cash flow ratio
9.33
5.52
2.4
1.49
1.26
0.61
5.77
Price to book ratio
9.56
24.04
2.98
2.48
3.17
1.63
10.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.08
0.43
0.33
0.66
0.34
1.77
Return on equity %
0.18
0.48
2.11
5.42
46.22
0.53
54.28
Return on invested capital %
—
—
—
—
—
-403.37
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
403.37
287.87
244.29
-3 759.7
2 055.56
-1 171.99
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
141.63
315.5
253.43
-4 311.94
2 574.6
-1 168.41
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.23
1.12
1.14
0.93
0.78
3.61
6.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.11
0.15
-0.01
0.01
0.26
Solvency ratios
Debt to assets ratio
—
0.58
—
—
—
—
—
Debt to equity ratio
—
3.46
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.56
0.51
0.58
0.52
0
1.61
Long term debt to total equity ratio
0.04
3.35
2.48
9.38
36.58
0
48.45
Per share metrics
Operating cash flow per share
0.08
0.09
0.14
0.1
0.09
0.07
0.41
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
0.29
—
—
—
—
—
Cash per share
0.23
0.43
0.24
0.23
0.11
0.11
0.69
Net current asset value per share
0.24
0.43
0.25
0.26
0.12
0.14
0.78
Tangible book value per share
0.08
0.08
0.06
0.02
0
0.14
0.23
Working capital per share
0.05
0.05
0.03
-0.02
-0.03
0.1
0.08
Book value per share
0.08
0.08
0.06
0.02
0
0.14
0.23
News
H.C. Wainwright cuts FibroBiologics stock price target to $4
FibroBiologics shareholders approve reverse stock split and warrant share issuances
FibroBiologics gets Nasdaq extension to meet listing rules
FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026
FibroBiologics reports positive results for disc degeneration therapy
FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal
FibroBiologics stock maintains Buy rating at H.C. Wainwright on psoriasis IND filing
FibroBiologics files IND application for psoriasis treatment
Fibrobiologics stock rises after FDA filing for psoriasis treatment
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/23/25 - TipRanks.com
FibroBiologics closes $1.7 million registered direct offering
FibroBiologics raises $1.7 million in registered direct offering